BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 8103956)

  • 1. Criteria for medical as opposed to surgical treatment of prolactinomas.
    Besser M
    Acta Endocrinol (Copenh); 1993 Jul; 129 Suppl 1():27-30. PubMed ID: 8103956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of resistant prolactinomas.
    Olafsdottir A; Schlechte J
    Nat Clin Pract Endocrinol Metab; 2006 Oct; 2(10):552-61. PubMed ID: 17024154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of surgery for the treatment of prolactinomas.
    van't Verlaat JW
    Acta Endocrinol (Copenh); 1993 Jul; 129 Suppl 1():34-7. PubMed ID: 8103958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medical therapy of prolactinomas.
    Jaquet P
    Acta Endocrinol (Copenh); 1993 Jul; 129 Suppl 1():31-3. PubMed ID: 8103957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and histological correlations in prolactinomas, with special reference to bromocriptine resistance.
    Delgrange E; Sassolas G; Perrin G; Jan M; Trouillas J
    Acta Neurochir (Wien); 2005 Jul; 147(7):751-7; discussion 757-8. PubMed ID: 15971099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of macroprolactinomas at Auckland Hospital 1975-91.
    Wallace EA; Holdaway IM
    N Z Med J; 1995 Feb; 108(994):50-2. PubMed ID: 7885646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The treatment of prolactinoma].
    Serri O; Somma M; Beauregard H; Rasio E; Comtois R; Aris-Jilwan N; Boucher A; Hardy J
    Union Med Can; 1993; 122(6):496-9. PubMed ID: 7905686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Medical treatment of prolactin and growth hormone-secreting pituitary tumors].
    Jadresic A
    Rev Med Chil; 1997 Nov; 125(11):1383-8. PubMed ID: 9609063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment of hypophyseal prolactin-secreting macroadenomas].
    Candrina R; Tosoni M
    Recenti Prog Med; 1989 Sep; 80(9):471-3. PubMed ID: 2595078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 10-year follow-up study comparing primary medical vs. surgical therapy in women with prolactinomas.
    Andereggen L; Frey J; Andres RH; El-Koussy M; Beck J; Seiler RW; Christ E
    Endocrine; 2017 Jan; 55(1):223-230. PubMed ID: 27688009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Management of prolactinomas during pregnancy].
    Chen W; Bian X; Gai M; Zhang Y
    Zhonghua Fu Chan Ke Za Zhi; 2002 Jun; 37(6):335-7. PubMed ID: 12126566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined treatment of invasive giant prolactinomas.
    Yu C; Wu Z; Gong J
    Pituitary; 2005; 8(1):61-5. PubMed ID: 16411070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulated, adenovirus-mediated delivery of tyrosine hydroxylase suppresses growth of estrogen-induced pituitary prolactinomas.
    Williams JC; Stone D; Smith-Arica JR; Morris ID; Lowenstein PR; Castro MG
    Mol Ther; 2001 Dec; 4(6):593-602. PubMed ID: 11735344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The impact of prolactinoma in human reproduction].
    Hurtado Amador R; Ayala AR; Hernández Marín I
    Ginecol Obstet Mex; 2004 Jan; 72(1):3-9. PubMed ID: 15239558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical management of prolactinomas.
    Webster J
    Baillieres Best Pract Res Clin Endocrinol Metab; 1999 Oct; 13(3):395-408. PubMed ID: 10909431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term outcome of patients with macroprolactinomas initially treated with dopamine agonists.
    Kars M; Pereira AM; Smit JW; Romijn JA
    Eur J Intern Med; 2009 Jul; 20(4):387-93. PubMed ID: 19524180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The best approach to treat prolactinoma].
    Zárate A; Saucedo R; Basurto L
    Gac Med Mex; 2004; 140(5):567-9. PubMed ID: 15559242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medically treated prolactin-secreting pituitary adenomas: when should we operate?
    Vale FL; Deukmedjian AR; Hann S; Shah V; Morrison AD
    Br J Neurosurg; 2013 Feb; 27(1):56-62. PubMed ID: 22938595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Indications for surgery in the treatment of hyperprolactinemia.
    Zacur HA
    J Reprod Med; 1999 Dec; 44(12 Suppl):1127-31. PubMed ID: 10649823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Do the limits of serum prolactin in disconnection hyperprolactinaemia need re-definition? A study of 226 patients with histologically verified non-functioning pituitary macroadenoma.
    Karavitaki N; Thanabalasingham G; Shore HC; Trifanescu R; Ansorge O; Meston N; Turner HE; Wass JA
    Clin Endocrinol (Oxf); 2006 Oct; 65(4):524-9. PubMed ID: 16984247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.